Immunic
IMUX
$1.24
Share price
-0.40%
Change (1 day)
-31.22%
Change (1 year)
Categories
Earnings for Immunic (IMUX)
Earnings in 2023 (TTM): -$99.23 M
According to Immunic's latest financial reports the company's current earnings (TTM) are -$99.23 M. In 2022 the company made an earning of -$86.52 M an increase over its 2021 earnings that were of -$91.67 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Immunic from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$99.23 M | 14.68% |
| 2022 | -$86.52 M | -5.62% |
| 2021 | -$91.67 M | 87.18% |
| 2020 | -$48.98 M | 32.24% |
| 2019 | -$37.04 M | -3.59% |
| 2018 | -$38.41 M | -27.05% |
| 2017 | -$52.66 M | 27.6% |
| 2016 | -$41.27 M | -20.82% |
| 2015 | -$52.12 M | 9.34% |
| 2014 | -$47.67 M | 33.05% |
| 2013 | -$35.83 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 11.65% | 🇺🇸 USA |